Agriculture

Indigo Adds $250M as It Expands Reach Into Agricultural Supply Chain

One year ago   |   By Xconomy

Indigo Ag started as a company focused on microbial agriculture-finding microorganisms to develop into seed coatings intended to boost crop yields. While microbiology remains a focus, CEO David Perry says the startup is positioning itself to take on additional aspects of the agriculture business. Boston-based Indigo is revealing one of the ways it aims to reach deeper into agricultural transactions with the formal launch today of an online platform for selling grain. The startup is supporting this software, called Marketplace, in part with a $250 million Series E round of financing...
Read more ...

 


Search by Tags

   Agriculture      Agricultural      Microorganisms      Microbiology      Boston      Boston top stories      National blog main      National top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      AgtechFood      Alaska Permanent Fund      Baillie Gifford      Biotech      David Perry      Deals      Flagship Pioneering      Indigo      Indigo Ag      Investing      Investment Corporation of Dubai      IT      Life Sciences      Software      Startups      VC      Venture Capital  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

An Entrepreneur's Quest to Make Seattle a Genome Sciences Hub

An Entrepreneur's Quest to Make Seattle a Genome Sciences Hub

Ivan Liachko turned postdoctoral research at the University of Washington into a company whose genomics tools are now found in laboratories researching human, animal, and plant... Read more ...

Flagship's Omega Aims to Take Epigenetic Drugs a Step Further

Flagship's Omega Aims to Take Epigenetic Drugs a Step Further

A biotech startup called Omega Therapeutics debuts this morning touting a new approach to developing medicines based on epigenetics, a field of research that has tantalized... Read more ...

Strip Steak: Bacterial Enzyme Removes Inflammation-Causing Meat Carbohydrates

Read more ...

Perturbed Genes Regulating White Blood Cells Linked to Autism Genetics and...

Read more ...

Ionis subsidiary Akcea ousts leadership team

Biotech veteran Damien McDevitt takes over as interim CEO... Read more ...

Enough with the Insanity. We Need to Fix Cybersecurity Now

The year 2019 has been another dreadful period for cyberattacks. The most notorious lowlights include: -More than 40 municipalities , including Baltimore, Albany and 22 cities... Read more ...

Why the lettuce mitochondrial genome is like a chopped salad

The mitochondrion, "the powerhouse of the cell." Somewhere back in the very distant past, something like a bacterium moved into another cell and never left, retaining some of... Read more ...

DNA is held together by hydrophobic forces

Researchers at Chalmers University of Technology, Sweden, have disproved the prevailing theory of how DNA binds itself. It is not, as is generally believed, hydrogen bonds... Read more ...

Gene therapy startup Passage Bio nabs Janssen neuro lead as CMO

Mere weeks after getting off a major $110 million series B round, well-funded Passage Bio has grabbed a new C-suite member on top of its cash haul. Read more ...

Clovis strikes 3B deal to move into radiopharmaceuticals

Clovis Oncology has paid $12 million for rights to FAP-targeted radiopharmaceuticals in development at 3B Pharmaceuticals. The deal gives Clovis the ex-Europe rights to a... Read more ...